Requires a GAO study on AI's role in detecting and combating illicit online fentanyl and methamphetamine sales, focusing on algorithmic technologies, enforcement mechanisms, and interagency collaborations. Mandates a report to Congress within one year detailing findings.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding legislative act passed by the United States Congress that mandates a GAO study with specific requirements and a deadline for reporting to Congress.
The document primarily addresses risks related to malicious actors (4.2, 4.3) using AI and online platforms for illicit drug sales, AI system capabilities for detection (7.2, 7.3), and governance/enforcement mechanisms (6.5). It focuses on studying how AI technologies can combat illegal activities and examining interagency collaboration frameworks.
The document primarily governs AI use in the Information sector (online platforms and providers) and intersects with Public Administration (law enforcement) and Finance and Insurance (payment processing for illicit transactions). The focus is on studying how these sectors use AI to detect and combat online drug sales.
The document primarily focuses on the Deploy and Operate and Monitor stages, examining how AI systems (machine learning, algorithmic technology) are deployed by providers to detect illicit drug sales and how these systems are monitored for effectiveness. It also touches on verification through the study of enforcement mechanisms and outcomes.
The document explicitly mentions machine learning and algorithmic technology as AI models used by providers. It does not reference frontier AI, general purpose AI, foundation models, or specific compute thresholds. The focus is on task-specific AI systems deployed for detecting and combating illicit drug sales online.
United States Congress
The document is an Act of Congress, indicating that the United States Congress is the proposing body that initiated and passed this legislation.
United States Congress; Federal law enforcement agencies
Congress has oversight authority to ensure GAO compliance with the study mandate. The document also examines Federal law enforcement agencies' enforcement mechanisms against online drug sales.
Government Accountability Office (GAO); United States Congress
The GAO is tasked with monitoring and studying the effectiveness of AI technologies and enforcement mechanisms. Congress will monitor the GAO's completion of the study through the required report.
Government Accountability Office (GAO); providers (online platforms); Federal law enforcement agencies
The Act targets the GAO to conduct the study, and the study itself examines providers (online platforms using AI for detection) and Federal agencies' enforcement efforts against online drug sales.
7 subdomains (2 Good, 5 Minimal)